Episode 512: ENZA-P Nature Medicine translati...

Tanya Dorff joins Tom and Brian to discuss her ASCO 2026 data on a novel dual targeting ADC in prostate cancer. The broader scope of ADC development in prostate cancer is discussed with a focus on cytopenia toxicity and future direcctions. 

This comprehensive podcast covers the latest advances in prostate, bladder, and kidney cancers from ASCO 2026, including new therapies, trial data, and practice-changing insights. Brian, Tom and Silke analyze recent studies, controversies, and future directions in GU oncology. 

In this episode Dr Kyle Winik is joined by Dr Lervasen Pillay, a Sport and Exercise Physician who has a keen interest in Exercise and Cancer. Through the episode they discuss an approach to a patient battling cancer and try to give an approach to change the narrative that exercis ...  Show more

New research on prostate cancer screening and diet. This episode features audio from: The Pros and Cons of Testing PSA Levels for Prostate Cancer Changing a Man’s Diet After a Prostate Cancer Diagnosis Natural Dietary Treatments for Enlarged Prostate BPH Visit the video pages for ...  Show more

Welcome back to the Hot Topics podcast from NB Medical with Dr Neal Tucker. In this episode, we look at three new pieces of research and have a special interview in conjunction with Prostate Cancer UK. First, do antidepressants have physiological side effects? How do they compare ...  Show more

Thiazide diuretics (2:20), pancreatic cancer (4:40), DermTech pigmented lesion assay (8:30), chronic low back pain (17:00), hearing aids (23:40), and blood pressure cuff size (27:50).